JP2022513152A5 - - Google Patents

Info

Publication number
JP2022513152A5
JP2022513152A5 JP2021530284A JP2021530284A JP2022513152A5 JP 2022513152 A5 JP2022513152 A5 JP 2022513152A5 JP 2021530284 A JP2021530284 A JP 2021530284A JP 2021530284 A JP2021530284 A JP 2021530284A JP 2022513152 A5 JP2022513152 A5 JP 2022513152A5
Authority
JP
Japan
Application number
JP2021530284A
Other languages
Japanese (ja)
Other versions
JPWO2020109439A5 (https=
JP2022513152A (ja
JP7642538B2 (ja
Filing date
Publication date
Priority claimed from US16/206,526 external-priority patent/US20200174016A1/en
Application filed filed Critical
Publication of JP2022513152A publication Critical patent/JP2022513152A/ja
Publication of JPWO2020109439A5 publication Critical patent/JPWO2020109439A5/ja
Publication of JP2022513152A5 publication Critical patent/JP2022513152A5/ja
Application granted granted Critical
Publication of JP7642538B2 publication Critical patent/JP7642538B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021530284A 2018-11-30 2019-11-28 腫瘍療法の診断マーカー及び治療標的としてのMyb関連転写因子(MYPOP) Active JP7642538B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16/206,526 US20200174016A1 (en) 2018-11-30 2018-11-30 Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy
US16/206,526 2018-11-30
PCT/EP2019/082845 WO2020109439A1 (en) 2018-11-30 2019-11-28 Myb-related transcription factor (mypop) as diagnostic marker and therapeutic target for tumor therapy

Publications (4)

Publication Number Publication Date
JP2022513152A JP2022513152A (ja) 2022-02-07
JPWO2020109439A5 JPWO2020109439A5 (https=) 2023-01-11
JP2022513152A5 true JP2022513152A5 (https=) 2023-01-11
JP7642538B2 JP7642538B2 (ja) 2025-03-10

Family

ID=68848224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021530284A Active JP7642538B2 (ja) 2018-11-30 2019-11-28 腫瘍療法の診断マーカー及び治療標的としてのMyb関連転写因子(MYPOP)

Country Status (5)

Country Link
US (2) US20200174016A1 (https=)
EP (1) EP3887550A1 (https=)
JP (1) JP7642538B2 (https=)
CA (1) CA3121047A1 (https=)
WO (1) WO2020109439A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2721179A4 (en) * 2011-06-16 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L BIOMARKER COMPOSITIONS AND METHOD THEREFOR

Similar Documents

Publication Publication Date Title
BR112021017339A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021017728A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018093A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)
BR112021015080A2 (https=)
BR112021018584A2 (https=)
BR112021017310A2 (https=)
BR112021017949A2 (https=)
BR112021018084A2 (https=)
BR112019016136A2 (https=)
BR112021017983A2 (https=)